Veozah vs HRT: The Non-Hormonal Hot Flash Treatment Explained

Veozah (fezolinetant) represents a genuinely new approach to hot flash treatment. Rather than replacing hormones, it targets the brain mechanism that causes hot flashes in the first place.

Here's the science: hot flashes happen because declining estrogen destabilizes your brain's thermostat — the KNDy (kisspeptin/neurokinin B/dynorphin) neurons in the hypothalamus. When estrogen drops, these neurons become hyperactive and signal the body to dissipate heat, even when you're not actually warm.

The key chemical in this signaling cascade is neurokinin B (NKB), which acts through NK3 receptors. Veozah is a selective NK3 receptor antagonist — it blocks the signal that tells your brain to trigger a hot flash.

This mechanism was discovered through research on a rare genetic condition where people born without NK3 receptors never experience flushing. Scientists realized: block the receptor, block the hot flash.

Veozah was FDA-approved in May 2023 and is the first non-hormonal prescription specifically designed for vasomotor symptoms. It's taken as a 45mg pill once daily.

In clinical trials (SKYLIGHT 1 and SKYLIGHT 2), Veozah reduced [hot flash](/blog/hot-flashes-menopause-causes-triggers-treatments) frequency by approximately 60% and significantly reduced severity by week 4, with continued improvement through week 12.

HRT (hormone replacement therapy) remains the most effective treatment for [hot flashes](/blog/hot-flashes-menopause-causes-triggers-treatments), reducing frequency by 75-90% and providing additional benefits for bones, mood, cardiovascular health, and vaginal symptoms.

Veozah is effective but narrower — it treats hot flashes and night sweats only. It doesn't provide the bone, cardiovascular, cognitive, or [vaginal](/blog/vaginal-dryness-menopause-treatments-that-work) benefits that HRT does.

However, Veozah fills a critical gap for women who cannot or choose not to take HRT.

Veozah is most valuable for women in specific situations:

Breast cancer survivors — especially those on aromatase inhibitors (letrozole, anastrozole) which worsen hot flashes. HRT is generally contraindicated for ER-positive breast cancers. Veozah provides relief without hormonal exposure.

Women with blood clot history or risk — while [transdermal HRT](/blog/hrt-patch-vs-gel-vs-pill-which-delivery-method-is-best) doesn't increase clot risk, some women and doctors prefer a completely non-hormonal approach.

Women who prefer non-hormonal treatment — personal choice matters. Some women don't want to take hormones for philosophical, cultural, or comfort reasons.

Women who tried HRT and couldn't tolerate it — some women experience side effects (breast tenderness, spotting, mood changes) that make HRT difficult to continue.

Women who only need hot flash relief — if hot flashes are your main symptom and you don't need the bone, cardiovascular, or vaginal benefits of HRT, Veozah addresses the specific problem.

Veozah is NOT the best choice if you need comprehensive menopause management (mood, bones, heart, vaginal health) — HRT addresses all of these while Veozah only targets vasomotor symptoms.

Veozah side effects: - Elevated liver enzymes (requires monitoring with blood tests at baseline, 3 months, 6 months, then every 6 months) - Abdominal pain (4-5%) - Diarrhea (3-4%) - Insomnia (3%) - Back pain (3%)

The liver enzyme concern is the main safety consideration. Veozah is contraindicated in women with cirrhosis or severe liver impairment. Routine liver function monitoring is mandatory.

Coming next: Elinzanetant (Lynkuet) A dual NK1/NK3 receptor antagonist approved by the FDA in early 2025. It targets both hot flashes AND sleep disruption (the NK1 receptor is involved in sleep regulation). Early data from the ATTAIN trials suggests elinzanetant may provide: - Similar hot flash reduction to Veozah (~60%) - Additional sleep quality improvement - Potential mood benefits (NK1 receptors are involved in anxiety/depression) - Possibly better liver safety profile

Elinzanetant could become the preferred non-hormonal option because it addresses the [sleep disruption](/blog/night-sweats-in-menopause-causes-and-treatments-that-stop-them) that often accompanies hot flashes.

For the most current information on both medications and whether they might be right for you, talk to your provider or a [menopause specialist](/blog/hrt-menopause-telehealth-guide-2026).